Literature DB >> 29316827

Downregulation of MAGE family member H1 enhances hepatocellular carcinoma progression and serves as a biomarker for patient prognosis.

Peng-Cheng Wang1, Zhi-Qiang Hu1, Shao-Lai Zhou1, Hao Zhan1, Zheng-Jun Zhou1, Chu-Bin Luo1, Xiao-Wu Huang1.   

Abstract

AIM: The MAGE family member H1 (MAGEH1) belongs to melanoma-associated antigen (MAGE) superfamily. The role of MAGEH1 in hepatocellular carcinoma (HCC) is largely undefined. MATERIALS &
METHODS: We used quantitative reverse transcription PCR and immunohistochemistry to detect MAGEH1 expression in HCC tissues. CCK-8 assay, wound healing migration assay and Transwell Matrigel invasion assay were used to measure HCC cell proliferation, migration and invasion ability.
RESULTS: MAGEH1 expression was downregulated in HCC tumor tissues compared with adjacent normal liver tissues and in samples from patients with tumor recurrence. MAGEH1 reduced HCC cell proliferation, migration and invasion ability. Low MAGEH1 expression was significantly correlated with poor prognosis in HCC patients.
CONCLUSION: MAGEH1 may serve as a potential biomarker and a new prognostic factor for HCC.

Entities:  

Keywords:  MAGEH1; hepatocellular carcinoma; prognosis

Mesh:

Substances:

Year:  2018        PMID: 29316827     DOI: 10.2217/fon-2017-0672

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  5 in total

1.  The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.

Authors:  Dan Li; Kai Li; Wei Zhang; Kong-Wu Yang; De-An Mu; Guo-Jun Jiang; Rong-Shu Shi; Di Ke
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

2.  Chromosome-specific retention of cancer-associated DNA hypermethylation following pharmacological inhibition of DNMT1.

Authors:  Ashley K Wiseman; Rochelle L Tiedemann; Huihui Fan; Hui Shen; Zachary Madaj; Michael T McCabe; Melissa B Pappalardi; Peter A Jones
Journal:  Commun Biol       Date:  2022-06-02

3.  Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.

Authors:  Chang-In Moon; William Tompkins; Yuxi Wang; Abigail Godec; Xiaochun Zhang; Patrik Pipkorn; Christopher A Miller; Carina Dehner; Sonika Dahiya; Angela C Hirbe
Journal:  Genes (Basel)       Date:  2020-05-01       Impact factor: 4.096

4.  Downregulation of Brain Enriched Type 2 MAGEs Is Associated With Immune Infiltration and Poor Prognosis in Glioma.

Authors:  Mohit Arora; Sarita Kumari; Jay Singh; Anita Chopra; Shyam S Chauhan
Journal:  Front Oncol       Date:  2020-12-23       Impact factor: 5.738

5.  Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma.

Authors:  Rong Tang; Xiaomeng Liu; Wei Wang; Jie Hua; Jin Xu; Chen Liang; Qingcai Meng; Jiang Liu; Bo Zhang; Xianjun Yu; Si Shi
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.